SCHEMBL22010625

SCHEMBL22010625

COC(=O)c1ccc(CBr)cc1S(N)(=O)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.56
CA1 P00915 5/20 0.56
CA9 Q16790 5/20 0.56
CA5A P35218 1/20 0.56
GAA P10253 3/20 0.46
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HTT P42858 2/20 0.44
ALOX15 P16050 1/20 0.44
TSHR P16473 1/20 0.44
CA12 O43570 4/20 0.42
CA14 Q9ULX7 4/20 0.42
CA7 P43166 2/20 0.41
PDK2 Q15119 1/20 0.41
PDK4 Q16654 1/20 0.41
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29253953 0.87 CA2 (0.58) CA2CA1CA9CA5AGAA
SCHEMBL21962935 0.86 CA2 (0.54) CA2CA1CA9CA5AGAA
SCHEMBL28483919 0.84 CA2 (0.55) CA2CA1CA9CA5AGAA
SCHEMBL30925089 0.83 CA2 (0.51) CA2CA1CA9CA5AGAA
SCHEMBL7933510 0.82 CA2 (0.52) CA2CA1CA9CA5AGAA
SCHEMBL31357368 0.82 CA2 (0.52) CA2CA1CA9CA5AGAA
SCHEMBL7735941 0.82 CA1 (0.39) CA2CA1CA9CA5AGAA
SCHEMBL5412365 0.82 CA2 (0.52) CA2CA1CA9CA5AGAA
SCHEMBL21962894 0.80 CA2 (0.61) CA2CA1CA9CA5AGAA
SCHEMBL7727266 0.80 CA2 (0.50) CA2CA1CA9CA5AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102100-A9 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2022-01-06 WO disclosed
WO-2020102100-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed